Umbilical cord blood or HLA-haploidentical transplantation: Real world outcomes vs randomized trial outcomes.
暂无分享,去创建一个
E. Leifer | Richard J. Jones | M. Grunwald | J. Magenau | H. Elmariah | M. Eapen | L. Morris | N. Majhail | E. Fuchs | J. Antin | Mei-Jie Zhang | Hamza Hashmi | C. Brunstein | Andrew R. Rezvani | F. Milano | P. O'Donnell | M. Horowitz | J. Mcguirk | Mariam Allbee- Johnson
[1] R. Soiffer,et al. HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis. , 2021, Blood.
[2] E. Leifer,et al. Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. , 2021, Blood.
[3] K. Ballen,et al. Optimal donor for African Americans with hematologic malignancy: HLA-haploidentical relative or umbilical cord blood transplant. , 2020, Biology of Blood and Marrow Transplantation.
[4] S. Montoto,et al. Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Wagner,et al. Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M. Labopin,et al. Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide , 2018, Cancer.
[7] P. Hari,et al. Current Use and Trends in Hematopoietic Cell Transplantation in the United States. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[8] C. Furberg,et al. The necessity for clinical reasoning in the era of evidence-based medicine. , 2013, Mayo Clinic proceedings.
[9] J. Wagner,et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. , 2013, Blood.
[10] Xu Zhang,et al. A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model , 2007, Comput. Methods Programs Biomed..
[11] Harlan M Krumholz,et al. Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.
[12] John O'Quigley,et al. Proportional hazards models with frailties and random effects , 2002, Statistics in medicine.
[13] David Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials , 2001, Annals of Internal Medicine.
[14] J P Klein,et al. Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. , 1999, Statistics in medicine.
[15] D.,et al. Regression Models and Life-Tables , 2022 .